A detailed history of Vantage Financial Partners Ltd., Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Vantage Financial Partners Ltd., Inc. holds 12,605 shares of JNJ stock, worth $1.96 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
12,605
Previous 12,230 3.07%
Holding current value
$1.96 Million
Previous $1.93 Million 4.76%
% of portfolio
0.47%
Previous 0.52%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $54,142 - $59,167
375 Added 3.07%
12,605 $1.84 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $128,056 - $134,260
-825 Reduced 6.32%
12,230 $1.93 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $149,240 - $162,852
-1,025 Reduced 7.28%
13,055 $2.05 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $249,200 - $279,168
-1,600 Reduced 10.2%
14,080 $2.19 Million
Q2 2023

Aug 08, 2023

SELL
$154.35 - $166.11 $11,576 - $12,458
-75 Reduced 0.48%
15,680 $2.6 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $37,762 - $45,065
250 Added 1.61%
15,755 $2.44 Million
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $44,055 - $49,442
275 Added 1.81%
15,505 $2.74 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $8,066 - $8,976
-50 Reduced 0.33%
15,230 $2.49 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $96,709 - $106,955
575 Added 3.91%
15,280 $2.71 Million
Q1 2022

May 02, 2022

BUY
$158.14 - $179.59 $31,627 - $35,918
200 Added 1.38%
14,705 $2.61 Million
Q4 2021

Jan 27, 2022

BUY
$155.93 - $173.01 $54,575 - $60,553
350 Added 2.47%
14,505 $2.48 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $12,112 - $13,460
75 Added 0.53%
14,155 $2.29 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $207,324 - $222,391
1,300 Added 10.17%
14,080 $2.32 Million
Q1 2021

May 05, 2021

BUY
$153.07 - $170.48 $15,307 - $17,048
100 Added 0.79%
12,780 $2.1 Million
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $20,566 - $23,607
150 Added 1.2%
12,680 $2 Million
Q2 2020

Aug 07, 2020

SELL
$128.81 - $155.51 $34,778 - $41,987
-270 Reduced 2.11%
12,530 $1.76 Million
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $55,570 - $76,995
500 Added 4.07%
12,800 $1.68 Million
Q4 2019

Jan 27, 2020

BUY
$127.5 - $146.44 $19,125 - $21,966
150 Added 1.23%
12,300 $1.79 Million
Q3 2019

Nov 07, 2019

BUY
$126.95 - $142.14 $19,042 - $21,320
150 Added 1.25%
12,150 $1.57 Million
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $59,017 - $64,908
-450 Reduced 3.61%
12,000 $0
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $221,112 - $266,112
1,800 Added 16.9%
12,450 $1.61 Million
Q2 2018

Aug 09, 2018

BUY
$119.4 - $131.76 $405,960 - $447,983
3,400 Added 46.9%
10,650 $1.29 Million
Q1 2018

May 07, 2018

BUY
$125.1 - $148.14 $906,975 - $1.07 Million
7,250 New
7,250 $929,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Vantage Financial Partners Ltd., Inc. Portfolio

Follow Vantage Financial Partners Ltd., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners Ltd., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners Ltd., Inc. with notifications on news.